Amgen strikes $10.4 billion deal for Onyx
August 26, 2013 at 02:25 AM EDT
Amgen reaches a deal on Sunday to buy fellow biotech Onyx Pharmaceuticals Inc. for roughly $10.4 billion, the latest proposed takeover aimed at tapping into growth expected from the cancer-drug industry.